![Jiuxiang Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jiuxiang Li
Vendite & Marketing presso China Nuokang Bio-Pharmaceutical, Inc.
Profilo
Jiuxiang Li is currently the Director-Marketing at China Nuokang Bio-Pharmaceutical, Inc. He previously worked as a Manager at Shenyang Shuangding Pharmaceutical Co., Ltd.
Dr. Li holds a doctorate degree from Shenyang Pharmaceutical University, a graduate degree from Dalian University, and an undergraduate degree from Shenyang Medicine College.
Posizioni attive di Jiuxiang Li
Società | Posizione | Inizio |
---|---|---|
China Nuokang Bio-Pharmaceutical, Inc.
![]() China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Vendite & Marketing | 23/11/2009 |
Precedenti posizioni note di Jiuxiang Li
Società | Posizione | Fine |
---|---|---|
Shenyang Shuangding Pharmaceutical Co., Ltd. | Corporate Officer/Principal | 01/12/2003 |
Formazione di Jiuxiang Li
Dalian University | Graduate Degree |
Shenyang Pharmaceutical University | Doctorate Degree |
Shenyang Medicine College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
China Nuokang Bio-Pharmaceutical, Inc.
![]() China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
Shenyang Shuangding Pharmaceutical Co., Ltd. |
- Borsa valori
- Insiders
- Jiuxiang Li